Truist Securities on The Pennant Group (PNTG), 'upbeat management meetings'

Truist Securities analyst David MacDonald reiterated a Hold rating and $28.00 price target on The Pennant Group (NASDAQ: PNTG).

The analyst commented: "We hosted upbeat management meetings with PNTG highlighting the company's complementary segments, favorable positioning and strong demand backdrop further aided by recent sizable M&A. We expect continued strong demand trends in HH&H (e.g. demographics, relative cost, patient preference), look for supply/demand imbalance to aid growth in Senior Living while clarity around HH reimbursement/the final rule remains a key NT focus. Financial flexibility remains solid post-AMED and the pipeline full, though we expect NT focus around integration of AMED assets. We have updated FY25 and FY26 estimates to reflect recent M&A and introduced FY27 estimates. "

For an analyst ratings summary and ratings history on The Pennant Group click here. For more ratings news on The Pennant Group click here.

Shares of The Pennant Group closed at $24.24 yesterday.

You May Also Be Interested In

• BofA Securities Starts Kanzhun Ltd. (BZ) at Neutral
• Golden Spike Resources plans name change, share consolidation and C$500K raise
• XP Inc. (XP) Tops Q2 EPS by 8c